The checkpoint kinase Chk2 has a key role in delaying cell cycle progressio
n in response to DNA damage. Upon activation by low-dose ionizing radiation
(IR), which occurs in an ataxia telangiectasia mutated (ATM)dependent mann
er, Chk2 can phosphorylate the mitosis-inducing phosphatase Cdc25C on an in
hibitory site, blocking entry into mitosis, and p53 on a regulatory site, c
ausing G, arrest. Here we show that the ATM-dependent activation of Chk2 by
gamma- radiation requires Nbs1, the gene product involved in the Nijmegen
breakage syndrome (NBS), a disorder that shares with AT a variety of phenot
ypic defects including chromosome fragility, radiosensitivity, and radiores
istant DNA synthesis. Thus, whereas in normal cells Chk2 undergoes a time-d
ependent increased phosphorylation and induction of catalytic activity agai
nst Cdc25C, in NBS cells null for Nbs1 protein, Chk2 phosphorylation and ac
tivation are both defective. Importantly, these defects in NBS cells can be
complemented by reintroduction of wild-type Nbs1, but neither by a carboxy
-terminal deletion mutant of Nbs1 at amino acid 590, unable to form a compl
ex with and to transport Mre11 and Rad50 in the nucleus, nor by an Nbs1 mut
ated at Ser343 (S343A), the ATM phosphorylation site. Chk2 nuclear expressi
on is unaffected in NBS cells, hence excluding a mislocalization as the cau
se of failed Chk2 activation in Nbs1-null cells, interestingly, the impaire
d Chk2 function in NBS cells correlates with the inability, unlike normal c
ells, to stop entry into mitosis immediately after irradiation, a checkpoin
t abnormality that can be corrected by introduction of the wild-type but no
t the S343A mutant form of Nbs1, Altogether, these findings underscore the
crucial role of a functional Nbs1 complex in Chk2 activation and suggest th
at checkpoint defects in NBS cells may result from the inability to activat
e Chk2.